Abstract

Covid-19 is a multi-system infection which predominately infects the lungs. This new disease can present as an asymptomatic infection to life threatening infections leading to death, making it a challenge for healthcare workers across the globe in this pandemic. Covid-19 pneumonia often shows a set pattern of symptom progression along its disease course, although the timing of each symptom may vary in different individuals. In this case report, we will discuss how a middle-aged man presented with late onset lung involvement in Covid-19 and progressively deteriorated. The logical, thoughtful management options that we chose at various stages of his disease which eventually led to his curearealso discussed here. We also see how different investigation results at different stages of the disease guides us towards taking decisions in the management of the disease successfully without use of immune-modulatory drugs like tocilizumab.

Keywords:Covid-19,secondary bacterial infection,neutrophilia, ferritin, LDH, antibiotics, dexamethasone, tocilizumab.